Kewaunee Scientific Corp

Kewaunee Scientific Corp (KEQU) Stock Analysis

$32.100

-0.806 (-2.51%)At close

Loading chart…
High
32.530
Open
32.530
VWAP
32.24
Volume
1.20K
Mkt Cap
122.74M
Low
32.100
Amount
38.63K
EV/EBITDA, TTM
0.00

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

kewaunee.com

AI analysis of Kewaunee Scientific Corp (KEQU)

Hold

Kewaunee Scientific Corp is currently a hold. The stock is priced at $32.92, with a forward P/E of 7.716, indicating potential value, but the recent decline in net income and revenue growth raises concerns. The RSI is at 45.633, suggesting it is neither overbought nor oversold, which means it may not be the best time to buy. The main risk is the 7.5% revenue drop reported in Q4, which could impact future performance.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 32.10
Low
—
Average
—
High
—

Valuation Metrics

The current forward P/E ratio for Kewaunee Scientific Corp (KEQU) is 7.72, compared to its 5-year average forward P/E of 12.75.

Forward P/E

Fair
5Y Average P/E
12.75
Current P/E
7.72
Overvalued
19.61
Undervalued
5.88

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
9.42
Current EV/EBITDA
0.00
Overvalued
13.70
Undervalued
5.15

Forward P/S

Undervalued
5Y Average P/S
0.54
Current P/S
0.00
Overvalued
0.82
Undervalued
0.26

Alphio AI Price Scenarios for KEQU

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%KEQU

$74.07

Scenario price

B

Base

Base · 50%KEQU

$63.47

Scenario price

B

Bear

Bear · 25%KEQU

$57.33

Scenario price

Events Timeline

2026-09-09 (ET)

19:30:00

US Indices Down for Third Day as Oil Prices Rise

16:30:00

Kewaunee Reports Q1 Revenue of $66.32M

2026-06-23 (ET)

17:30:00

Kewaunee Reports Q4 Revenue of $71.4M

2026-03-11 (ET)

16:10:00

Kewaunee Reports Q3 Revenue of $69.4M, Successfully Acquires Nu Aire

2025-09-10 (ET)

16:11:48

Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year

News

KEQU FAQ — answered by Alphio AI

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. It operates in the Industrials sector (LABORATORY APPARATUS & FURNITURE industry).

Kewaunee Scientific Corp is currently a hold. The stock is priced at $32.92, with a forward P/E of 7.716, indicating potential value, but the recent decline in net income and revenue growth raises concerns. The RSI is at 45.633, suggesting it is neither overbought nor oversold, which means it may not be the best time to buy. The main risk is the 7.5% revenue drop reported in Q4, which could impact future performance.

1 analysts cover KEQU: 1 rate it Buy, 0 Hold and 0 Sell.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading